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Abstract
Experimental neuroscience was for a long time mainly invasive, focused on the
subsystem level: individual cells, cellular populations, proteins or genes. Further-
more, the experiments were mainly done on laboratory animals. Nevertheless, a
lot of questions seem to be unanswered with such an approach. One of them
is the question of the nature of neurodegeneration. Connectomics suggests a
new systematic approach to experimental neuroscience. In this thesis, I have
described what is connectomics, what are its methods, and what knowledge is
already gained with it; finally, I provided basic information on the issue of neu-
rodegeneration and showed how a connectomics approach can help to answer
some questions related to it.
Keywords: Brain connectivity, neurodegeneration, Alzheimer’s disease,
Parkinson’s disease
Experimentálńı neurovědy byly po dlouhou dobu hlavně invazivńı, zaměřené
na úroveň subsystému: jednotlivé buňky, buněčné populace, proteiny nebo geny.
Pokusy se prováděly hlavně na laboratorńıch zv́ı̌ratech. Mnoho otázek se však
zdá být s takovým př́ıstupem nezodpovězeno. Jednou z nich je otázka povahy
neurodegenerace. Konnektomika navrhuje nový systematický př́ıstup k experi-
mentálńı neurovědě. V této práci já jsem popsala, co je to konnektomika, jaké
jsou jej́ı metody a jaké znalosti s ńı již byly źıskány; nakonec jsem uvedla základńı
informace týkaj́ıćı se problematiky neurodegenerace a ukázala jsem, jak konek-
tomický př́ııstup může pomoci odpovědět na některé otázky s ńı souvisej́ıćı.
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• AD - Alzheimer’s disease
• AI - Artificial intelligence
• AMPAR - The α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid re-
ceptor
• APP - Amyloid beta precursor protein
• ApoE - Apolipoprotein E
• CFJ - Creutzfeldt–Jakob disease
• CNS - Central nervous system
• CSF - Cerebrospinal fluid
• CST - Corticospinal tract
• CT - Computed tomography
• DMN - Default mode network
• DTI - Diffusion tensor imaging
• EEG - Electroencephalography
• EM - Electron microscopy
• FAD - Familial Alzheimer’s disease
• FTD - Frontotemporal dementia
• LOAD - Late-onset Alzheimer’s disease
• LTD - Long-term depression
• LTP - Long-term potentiation
• MRI - Magnetic resonance imaging
• NMDAR - The N-methyl-D-aspartate receptor
• PD - Parkinson disease




There are two pieces of data that inspire this thesis. At first, according to UN
2017 World Population Ageing report, the world population is getting older. As
expected, by the year of 2050, the number of older people will double. This
significant increase in life expectancy brings new challenges to humanity and
one of them is neurodegenerative diseases, which also drastically increase in their
occurrence. This means that in the future more people would seek for professional
help and reliable remedies. Still, although, the diseases are not understood and
considered fatal with a prognosis of 3 to 9 years for Alzheimer’s patients.
Second motivation comes from Google Ngram Viewer data collection, accord-
ing to which the word ”connectomics” started to appear near 2004, and then the
number of word incidents in the literature increased drastically and there is no
doubt it will rise even more. However, although the term is new, connectomics
existed for a much longer time, probably since the invention of the first MRI ma-
chines. However, only now these and similar machines are reaching the needed
speed, quality, and becoming more affordable, and together with them grow our
capabilities of fast and reliable analysis of the produced data. Together this is
allowing fields like connectomics to finally bloom.
Connectomics experimental approaches have advantages that are crucial for
the research of neurodegeneration. It offers noninvasive, in vivo methods that can
be done on humans, thus allowing to study patients directly. However, besides of
that, it also offers a new point of view on these pathologies.
Some questions cannot be answered with traditional approaches.
• Why is there a cognitive decline in patients with neurodegeneration?
• Why do sometimes symptoms vary between patients?
• Why do different neurodegenerative diseases start in different places?
• How does it spread throughout the whole brain?
For these and other questions, connectomics has answers to offer. And in this
thesis, I aim to describe both questions and answers and determine what makes
connectomics a nice tool for studying brain pathologies.
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1. Connectomics
1.1 Background for connectivity research
1.1.1 Synapses are the basis for neuronal connectivity
Biological sciences have been going through a lot of disagreements among its fel-
lows, but inside neuroscience, one of the most encountered debates dates to the
beginning of the last century. Back then, it was claimed that the nervous system
represents a single, continuous network, so that it is reticular. Some resisted
and claimed that it is contiguous rather than continuous so that there should
be connections between separate units. Among the most notable followers from
different sides of this conflict were Camillo Golgi and Santiago Ramón y Cajal,
who, despite the disagreement, shared the Physiology and Medicine Nobel Prize
in 1906 (Jones, 1999). The prize was given for the incredible histological achieve-
ments done by Santiago Ramon y Cajal using Golgi’s method of staining which
showed the presence of connections between two neighboring discrete units, now
known as neurons. He presented his great anatomical drawings of many neural
system structures and, it served as additional proof to the neuron connectivity
hypothesis (Cajal, 1906).
Another great neuroscientist, Sir Charles Sherrington, while working on the
textbook of Physiology 1897, suggested the term “synapse” for these connections
inspired by its Greek meaning which emphasizes contact to be an active process
(Tansey, 1997).
All above became the beginning of the Neuron Doctrine, which certainly dom-
inates in modern science. The Doctrine has established neurons as neural system
subunits, much like other cells in an organism but heavily interconnected in be-
tween themselves by means of synapses (Jones, 1999).
Neuron Doctrine was further confirmed after investigation of synapse morphol-
ogy with electron microscopy half a century later. And a synapse is recognized
based on the following features:
1. Synapse is found in a place of close contact of two membranes; in this place,
membranes are not myelinated as has been revealed on electron microscopy
images. Such a place is seen in images as a higher density locality on both
membranes. This is most prominent though on the postsynaptic membrane
due to the abundant presence of proteins like receptors and supportive ma-
chinery. This is referred to as postsynaptic density (Banker et al., 1974).
A neuron is said to be polarized and the signal goes in direction from the
presynaptic membrane to the postsynaptic one.
2. Rich clusters of mitochondria are also shown to be located in close proximity
to the synapse (Palay, 1956), suggesting a higher energy demand in these
regions.
3. On a presynaptic membrane in an active zone and close to it dense clusters
of synaptic vesicles are located. These vesicles contain neurotransmitters,
chemicals that travel through the synaptic cleft, and, thus, transmit signals
from one neuron to the other as shown in studies of Bernard Katz and Paul
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Fatt. The signal is transmitted in so-called “quants”, and release is said to
be probabilistic which is consistent with the vesicle functioning (Fatt and
Katz, 1952; Katz and Miledi, 1972).
Depending on the neurotransmitter used, synapses can be divided into two
categories - excitatory and inhibitory, where the excitatory ones promote postsy-
naptic membrane depolarization, and inhibitory - hyperpolarization (Eccles et al.,
1966, 1954).
Given that two neurons can communicate by means of synapses, the groups
of neurons are further organized in chains, or as they are called neural circuits.
Donald O. Hebb developed the theory now known under his name. The Hebbian
theory associates the functionality of neurons with the structure of their neural
circuits (Sejnowski, 1999). He postulated that the electrical activity of neurons
is conserved in connections between these neurons by the mechanism of neuronal
plasticity, thus, an experience is able to shape the anatomy of the nervous system.
With the modern technology of two-photon microscopy, one can now observe
these changes in the living mouse brain in real-time and then record synaptic
plasticity as an appearance, disappearance, or transformation of dendritic spines,
i.e. protrusions of dendrites that typically form synapses with axons (Grutzendler
and Gan, 2006). Example of such visualization of synaptic dynamics is shown in
Figure 1.
Figure 1: Figure illustrates synaptic dynamics observed with two photon mi-
croscopy in mouse barrel cortex neurons after whiskers trimming. Green ar-
row show the disappearing spines, orange - appearing, yellow - stable. Image is
adapted from (Holtmaat and Svoboda, 2009)
The basic mechanism suggested for synaptic plasticity and Hebbian learning is
long-term potentiation (Ganong et al., 1986). The phenomenon is described as an
increase in the excitability of neurons after repetitive, high-frequency stimulation
of these neurons (Bliss and Lømo, 1973). The model for LTP explains how electri-
cal stimulation orchestrate molecular mechanisms that lead to changes seemingly
on both pre- and postsynaptic membranes, these mechanisms include AMPAR,
that provide initial depolarization, and NMDAR, responsible for an increase of
intracellular Ca++ levels, and internal second messengers such as CaMKII, that
explain long-term changes on a postsynaptic membrane, such as increase in the
amount of AMPA receptors, and their conductivity (Bekkers and Stevens, 1990;
Collingridge and Bliss, 1987; Bosch et al., 2014). There is also an active mech-
anism of destruction of existing connections - the mechanism called long-term
depression, or LTD. LTD works in a similar manner as LTP operating with the
very same molecules but in an opposite fashion, thus, providing possible explana-
tion for mechanisms of forgetting, or disappearance of spines (Collingridge et al.,
2010).
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Considering all mentioned above, these active connections between neurons
everywhere in the nervous system provide a great background for the explanation
of many complex phenomena including such as remembering, forgetting, sensing,
thinking, but also illnesses of the brain are likely to start with these connec-
tions. Connections, or synapses, are organized in chains, and chains that are big
enough can be called networks. Such networks are dynamic enough to rearrange
under experience but stable enough to maintain the most vital functions. These
networks are the subject that connectomics studies.
1.1.2 Methodology of connectomics
In April 2003, the Human Genome Project was completed and thus was resolved
one of the greatest challenges of biological science. To fully read the genome
means to know all coding sequences of it or genes, and what their functional role
is. And in some ways, this definition is similar to the definition of connectomics
goals. One of the leading scientists in connectomics, Olaf Sporns in 2005 defined
connectome (Sporns et al., 2005) as
“comprehensive structural description of the network of elements and
connections forming the human brain”
In other words, a connectome is a map of all connections or synapses in
the brain. This map can be structural if physical synapses exist between two
neurons, or functional, if two neurons fire simultaneously, thus serving the same
visible cognitive function. And the goal of connectomics is to find this map and
learn to read it. Considering the human brain with its up to 1015 connections,
the second main division emerges. Some, including Olaf Sporns (Sporns et al.,
2005), subdivide connectomics as a branch of neuroscience into one that studies
the microscale and one that studies the macroscale, and the methodologies of
them significantly differ.
The common way of studying structural connectivity on the microscale is
the application of electron microscopy. The synaptic cleft is of a size range
from 20 nanometres to 40 nanometres and so, it is revealed with a high level
of detail with electron microscopy that reaches the resolution much below this
value. In connectomics, both transmission electron microscopy and scanning
electron microscopy are used. To map all synapses, simple imaging, however, is
not sufficient and techniques for visualizing the 3D structure of prepared tissues
are used. To do so, cubes of fixed tissue are shot slice by slice. Decades ago, slices
were made manually, preserved, and imaged. As the demand for this increased,
single automated techniques appeared to substitute manual cutting. First, the
microtome was built in to the microscope, allowing to image directly the fresh-
cut and reduce manual manipulation of samples. One such established method
is serial block-face scanning electron microscopy invented by Winfried Denk at
Max Planck Institute (Denk and Horstmann, 2004). Another method uses ionized
beams to create slices - the FIB-SEM method (Bosch et al., 2015).
After such a set of images is obtained, nothing is still known about the connec-
tome. To make the reconstruction of local neural circuits, the analysis that will
mark the neurons on each slice should be applied. During previous decades, in
studies like the one that reconstructed the full connectome of C. elegans (White
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et al., 1986), this process has to be done mostly manually only with some help
of computers; nowadays advances in computer vision helped to automate this
process. It is made with a segmentation process, and the selected cell and its
axons are used for the 3D reconstruction of the neuron model. Application of
machine learning and artificial intelligence further speed up the process. The
research group of Sebastian Seung even tries to overcome the problem of big data
analysis with crowdsourcing, they have created the public game Eyewire [1] that
aims to attract the public to help to control automated analysis, and companies
like Google (Li et al., 2019) are participating in connectome decoding by creat-
ing new powerful algorithms for segmentation. Since electron microscopy offers
such great resolution, it is applied in a big percentage of connectivity research
on a microscale. However, this method also has its own limitations, such as that
the images obtained are grayscale, and thus the segmentation process is more
complicated since it is harder to distinguish the objects of interest. Therefore,
some researchers try to overcome this with optical microscopy; with the advan-
tage of fluorescence, they are able to obtain colorful maps that are easier for
analysis. Using transgenic strategies, they are able to get many colors from just
a few fluorescent proteins by regulating their expression and so combining differ-
ent patterns of it. Here, Figure 2 shows an example of their results, where each
individual neuron possesses its own unique color (Livet et al., 2007).
Figure 2: Brain circuits visualized with transgenic staining techniques. From
(Livet et al., 2007)
Another method, called array tomography, combines both optical and electron
microscopy and visualizes ultrathin slices first colorized by fluorescent stains, and
later stained with heavy metals and imaged with electron microscopy (Micheva
and Smith, 2007).
The disadvantages of the methods listed above are that they can not be used
for revealing structures of bigger sizes, such as even parts of the human brain or
mouse brain. The second major disadvantage is that these methods can be only
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performed on the dead tissue. And lastly, all techniques involving microscopy are
clearly invasive and for more practical purposes, such as research on neurodegen-
eration, it is a crucial issue.
The most common noninvasive methods that are used in the macroscale are
CT, fMRI, PET, and DWI, and its special kind - DTI. These methods allow to
visualize the structural and chemical content of the brain.
They appeared to be massively available during the last decades of the last
century. X-rays were already a good way to visualize the internal structures of
the organisms, however, they were 2-dimensional images and for complex struc-
tures like lungs or brain, it provided very little information. However, when
multiple such images are combined, the result provides the necessary depth in-
formation, thus allowing it to differentiate between fluid and solid structures to
a much higher extent. The described method is a computerized tomography or
CT technique. Another method, suggested by Paul Lauterbur in 1973, MRI, a
technique based on the behavior of protons in the magnetic field, provides an
opportunity to differentiate between different types of molecules, as they provide
a different environment for protons and, thus, this affects how photons behave
in response to radio frequency waves, all in all, enabling to visualize differences
in brain structures (Lauterbur, 1973). Both methods are used for describing the
structure of the brain on a macroscale; MRI, although, is able to distinguish
well between dark and white matter. Considering that white matter consists of
myelinated axons, these scans provide some information on connectivity in the
brain. Nevertheless, the level of detail is rather very low, and it is impossible
to differentiate between individual axonal pathways or even some bundles in the
white matter. This can be also observed in Figure 3 which provides an example
of an MRI scan.
To overcome this, the diffusion tractography or DTI method was invented;
this method is often applied for visualizing long-range structural connectivity. In
this method, the properties of MRI are used to measure the degree of anisotropic
diffusion, as this type of diffusion occurs along elongated pathways, it reveals the
localization and directionality of individual axon bundles (Conturo et al., 1999).
Figure 4 illustrate this method capability with the visualization of corpus callo-
sum tracts. This method is an improved version of DWI, which is only able to
measure if there is a constraint for diffusion in tissue. Some more novel meth-
ods like Diffusion Spectrum Imaging, DSI, or High angular resolution diffusion
imaging, HARDI, aim to further improve these techniques for axonal pathways
visualization (Tuch et al., 2002).
For the description of functional connectivity, fMRI, PET, or EEG are used.
These techniques are called functional brain visualization because they allow us
to show not how the brain tissue is organized but what areas are active in a single
moment. To perform this, fMRI utilizes a phenomenon called BOLD or Blood
Oxygen Level-Dependent effect discovered by Seiji Ogawa (Ogawa et al., 1990).
This phenomenon means that active neurons use more oxygen than nonactive,
and, thus, investigators can visualize the magnetic behavior of oxygen-carrying
hemoglobin and oxygen-free molecules. PET technique as an alternative to fMRI
also provides functional information about the brain. PET can be used with a
great variety of different biomarkers, the most popular is the radioactive version
of glucose, fludeoxyglucose, or FDG for short. As glucose travels primarily to the
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Figure 3: A) CT scan, B) MRI scan, C) PET scan, D) fMRI scan. Adapted from
Wikipedia [5].
Figure 4: Example, of DTI image of corpus callosum that connect both brain
hemispheres, and brain stem. Adapted from Wikipedia [6].
7
brain regions which are more active, this method also can indirectly show which
regions and to what extent react to different kinds of tasks. By experimenting
with different human activities, these tools reveal what brain regions are organized
in functional units and show a response for the same activity.
Figure 3 shows the comparison between different types of classical brain imag-
ing techniques.
All together, modern techniques provide a large variety of tools for visualizing
brain connectivity. However, to gain a full connectome information, one should
be able to analyze and integrate all obtained knowledge. This can be done with
network science approaches.
1.1.3 Network neuroscience
Here, connectomics intersects with network science, the subject of which greatly
varies, since networks are all social connections, protein interaction maps, the
internet, or the brain. The main tool that network science uses is the mathemat-
ical field of graph theory. It can be said that graph theory was first mentioned
by Leonhard Euler in the 18th century when he introduced the problem of Seven
Bridges of Konigsberg (Hopkins and Wilson, 2018). As the name suggest, graph
theory explores the mathematical structure that is called a graph, where the
graph is an ordered pair of vertices and edges or, in mathematical notation
G = (V, E)
where V is the set of all vertices
E ⊆ {x, y|x, y ∈ V, x ̸= y} is a set of edges
In this sense, the neuronal system is a perfect graph as it consists of vertices
or neurons, and edges or synapses. A graph can further be undirected or directed,
if the connection exists from node V1 to V2 and back, or only in one direction,
respectively. There are a series of terms central to graph theory, and further, we
will review some of them.
One of the most useful ways to describe a vertex is to count how many edges,
thus other vertices, connect to it, this number is called the degree of a vertex, and
it carries the information about the role that each particular vertex plays in the
whole network. One can look at all vertices and calculate the degrees for each,
then create a degree distribution for the graph. This simple measure will already
tell a lot about the graph as will be seen later on in the example of hubs and rich
clubs.
In graph theory, one of the most popular problems is the problem of cost
optimization. Suppose that each edge costs a particular price, and one has an n
number of vertices to connect, the problem puts a question:
“What would be the optimal way to connect vertices, given that we
want to have the lowest cost possible?”
In biological systems, it seems to be closely connected to a path length, or a
distance between two neuron bodies. As axons and dendrites fill in the physical
space inside the body, and their maintenance takes some resources from this as
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well, they put a certain constraint on the nervous system during its development
and evolution. This can be also seen from the perspective of wiring cost and
graph theory. And, indeed, it was shown in C.elegans and, even in larger brains,
in part of the brain called lamina cartridge of Drosophila melanogaster that the
neuron’s layout is partially guided by cost optimization as different models of cost
optimization can predict the real layout of neurons (Chen et al., 2006; Rivera-Alba
et al., 2011).
To describe a graph, instead of drawing it, which would be too complex for
bigger graphs, connectivity (adjacency) matrices are used. Suppose a matrix A
of the size n × n. In such a matrix, the indices would be assigned to each neuron,
and the value aij ∈ A would show the number of connections between neurons
with indices i and j. Or a matrix can be binarized, so that a matrix would consist
of only 0 and 1, so to assign 0 for no connection in between two neurons, and 1
if at least 1 connection exist.
Most of the real-world graphs are said to be complex networks as opposed to
random graphs or regular lattices (Bullmore and Sporns, 2009). Complex graphs
show up certain properties, which can be described and analyzed. Examples of
complex graphs are scale-free and small-world graphs. A small-world graph was
introduced by Watts and Strogatz in a 1998 paper (Watts and Strogatz, 1998) as
a graph whose topology is somewhere in between a regular graph and a random
graph. Figure 5 shows the illustration of such graph. This graph is characterized
as having a high clustering coefficient, where the clustering coefficient is the
measure of graph nodes tendency to cluster, or to be fully connected inside a
given neighbourhood. The term small-worldness refers to the commonly known
phenomenon of six handshakes, or, in other words, to the fact that each node can
be reached from another node by relatively few steps through their intermediates.
This relative closeness is the main feature of small-world graph. Such graphs, they
argue, are met everywhere in the real world including C. elegans nervous system.
Figure 5: Illustration of small-world graph. Adapted from (Watts and Strogatz,
1998)
Other two important concepts in the field of network science are hubs and
rich clubs. The already mentioned degree distribution for a particular graph can
show up if the graph is complex or random. For a random graph this distribution
would be uniform, but for nonrandom complex graphs the distribution can be
Gaussian or power-law. This is due to the existence of nodes with a high degree
in the network, in other words, of hubs. The rich club appears when such hubs
are more interconnected in between themselves than with other nodes. Since
the creation of rich clubs accounts for a high wiring cost, some speculate that
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it can be seen as a trade-off between network constraints and biological function
(Towlson et al., 2013). Studies show that neurons in rich clubs are often displaying
functional centrality comprising information from many inputs; they are able to
evaluate it and give a single output, as a central motor neurons in C. elegans
(Towlson et al., 2013), or superior frontal cortex in humans (Heuvel and Sporns,
2011).
The similar definition is the graph module. In a graph, a module is a group of
nodes with a maximum number of edges within the group and a minimum number
of edges with other groups outside (Rubinov and Sporns, 2010). Optimization of
a network according to its wiring cost by itself entails reorganization of a network
into modules. But as we will see it may be also explained from the organism’s
biology and anatomy constraints, so as to be shaped by functional needs (Pan
et al., 2010).
1.2 Caenorhabditis elegans connectome and mi-
croscale connectivity
Still up to today, C. elegans is considered to be the only animal for whom we
have a full complete connectomic map. This work started under the name of
Sydney Brenner, who popularized C.elegans as a model organism. Back then, the
map was created with an enormous effort by his team who mapped each neuron
and all connections almost manually through a huge dataset of EM micrographs
(White et al., 1986). Though the map that they have made was still incomplete
and the work was fully done after additional efforts of other scientific groups
(Chen et al., 2006). Firstly made for hermaphrodite, now it is available for both
sexes, male and hermaphrodite (Cook et al., 2019). This work resulted in a full
C.elegans connectome dataset which is publicly available [2] today. The result
mapped all 302 neurons, 132 muscles, and 26 non-muscle end organs with its 4,887
chemical synapses, 1,447 electrical junctions, and 1,410 neuromuscular junctions
for hermaphrodite, a slighter bigger number of nodes is observed for male species
and, as authors mention, data for both sexes are similar but not identical. The
biggest differences are in mating behavior-related neuronal pathways (Cook et al.,
2019). The knowledge of the precise positions of each neuron has given us the
ability to analyze the data with graph theory and to look for the functional and
evolutionary meaning of the observed structure.
The full map, even for as little as 300 neurons, is difficult to comprehend and
requires deeper analysis and certain commentary. The nervous system is orga-
nized to provide a hierarchical information flow from sensory neurons (here and
further in Figure 6 shown as triangles of different colors) through interneurons
(hexagons) to the output motor neurons (oval or circles in Figure 6) and then
to muscle or nonmuscle end organs (shown as rectangles). Sensory neurons are
described based on the stimuli they react to. Interestingly, from the degree dis-
tribution of sensory neurons, we do know that it has a wide set of high degree
neurons, and it is estimated that information from sensory neurons is able to
reach around 70-98 % of all neurons. The interneurons are distinguished into 5
classes based on the output and pathways that they facilitate. Motor neurons
make almost half of the whole nervous system, most are connected to somatic
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muscles through neuromuscular junctions, and they can be placed in 46 different
classes (Cook et al., 2019).
The nervous system of C.elegans is a complex network, because of the small
average path length and it has high clustering coefficients when compared to a
random graph (Varshney et al., 2011). To generalize, similar findings were also
gained for rat cortical neurons and for human brain connectome (Hagmann et al.,
2007; Song et al., 2005). The knowledge of that allows us to compare C.elegans
nervous system with other complex networks that occur in real life. Also, for com-
plex networks, it is known that nodes are organized into clusters, modules, and
rich clubs. Studies that examine the modular composition of C.elegans nervous
system show that it exhibits a strong modular topology and that these modules
are originating from functional rather than anatomical constraints (Sohn et al.,
2011; Pan et al., 2010). This is shown mainly because the neurons in specific
clusters do not overlap with neurons within specific ganglia, but it is more likely
in one module one will find neurons participating in one functional role.
Let us take a closer look at a C. elegans example, ALM, AVM, PLM, and PVD
- specific sensory neurons (triangles in the Figure 6), functionally provide sensing
of touch, and they fall into a single cluster; this cluster in its turn, contains also
command interneurons, AVD and PVC (as some of the hexagons in the same
Figure 6), which transmit mechanosensory inputs to motor neurons (Sohn et al.,
2011). The similar thing is shown for other functional roles as well. Sohn also
shows how these functional modules are organized on a higher level (Sohn et al.,
2011), so how separate modules are further integrated to create more complex
behaviors. And the study of the rich club organization of C.elegans nervous
system shows that interaction between modules is facilitated by rich clubs and
helps to integrate functional subunits to organize one consistent response, as in
the example of organized locomotion (Towlson et al., 2013).Thus, it shows that
examining modular composition and clustering can help us understand better
how the behavior is born.
The aim of further research would be to translate rich structural informa-
tion into an understanding of C.elegans behavioral patterns like feeding, mating,
locomotion. One study, for example, showed which neurons and in what way in-
teract to produce klinotaxis (Izquierdo and Beer, 2013). This was done by search
through paths from chemosensing neurons to neck motor neuron, and authors
have shown how sensing neurons are able to estimate a gradient fall, transfer the
information to interneurons, which synchronize with the oscillatory movements
information, and affect this movement according to the following information
about chemical gradient. Similar work was also made for mating behavior in C.
elegans (Jarrell et al., 2012). Another study used network control principles to
predict, which particular neurons in a network are crucial for locomotion, and, in
general, how many classes of neurons are required for successful locomotion (Yan
et al., 2017); notable, they were able to control this prediction using experimental
methods, thus, proving that network science predictions are a valuable source of
information about the nervous system.
All in all, there is plenty of what we can learn from knowing C. elegans con-
nectome. First of all, the connectome of smaller animals gives an opportunity to
check the methodology. Thus, successes here should motivate to use the same
approach further. Secondly, even though the C. elegans connectome was ob-
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Figure 6: Map of connections of C. elegans nervous system. Above shown
hermaphrodite species, and below is male. Adapted from (Cook et al., 2019)
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tained from electron micrograph reconstruction, which seems nearly impossible
for now to perform on the human brain, a lot can be understood about the human
brain from this work. Authors also point out that some properties like degree
distribution or some motif frequency show similarities with other studies of the
mammalian cortex (Chen et al., 2006).
1.3 Human connectome
Before going to macroscopic structural and functional brain organization, it is
worth mentioning that some are also studying mesoscopic connectivity. Such
studies reveal the finest details of local circuits and details of microarchitecture
in larger brains. Like, for example, the study of fine columnar architecture in
rats reveals that excitatory neurons inside one column of the cortex have their
own connectivity patterns with selective connections to specific layers (Loftus and
Anderson, 2005).
Another study used DTI to show the precise structure of thalamocortical con-
nections in humans (Behrens et al., 2003). This helped not only to define strictly
the thalamus-cortex connectivity but also shed light on thalamic cytoarchitecture
where it is easier to use projections to the cortex to define functionally distinct nu-
clei or subregions of thalamus than to use any other non-invasive method. Figure
7 shows the thalamic division based on this method.
Figure 7: The resulted segmentation from (Behrens et al., 2003), (a) cerebral
cortex divided by anatomical landmarks, (b) axial section of thalamus based on
histological atlas, (c) and (d) show predicted by connectivity division of thalamus.
Color code define connected part to the respective area in cortex.
Similar works are done on different levels of detail and for different areas of the
brain. In the future, such studies could be integrated into studies of large-scale
connectivity and explain what internal architecture makes it possible for these
units to act as a whole and carry out their functional role. As well as it would
improve the precision and overall quality of larger-scale works.
The goal of macroscopical structural connectomics is for the whole human
brain to define its regions with precise border discrimination and the connections
between these regions. A similar goal was already achieved for the primate’s
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cortex (Felleman and Essen, 1991) or cat’s cortico-thalamic system (Scannell
et al., 1999). However, due to its enormous size, most of the macroscopical
structural studies still work only on a part of it. Mostly, only some parts of white
matter are described. The main white matter tracts extracted with DTI are the
cingulum, fornix, corpus callosum, the corticospinal tract (CST), the uncinate and
superior longitudinal fasciculus, and the inferior and fronto-occipital fasciculi.
To collect and integrate all data into one database that could be further used
for analysis, the Human Connectome Project [3] was initiated in July 2009, it
was planned to be completed in 2018, however, is still in progress.
Anatomical data alone, however, are insufficient to fully reveal brain organi-
zation principles. A lot of useful information comes from fMRI or EEG studies.
These studies show which areas of the brain “communicate” with each other dur-
ing each specific task, even though not always anatomically directly connected.
Resting-state fMRI reveals general properties of functional networks as opposed
to studies of task-dependent activity.
One of the most studied functional networks is the default mode network
(DMN). It consists of areas that are suspended during task-related activities
(Raichle et al., 2001). These regions include the anterior and posterior cingulate,
the lateral parietal lobes, and the medial and lateral temporal regions, Figure 8
shows the fMRI resting-state scan showing DMN regions. Some of these areas
include the highly connected structural and functional core of the brain - the
posterior cingulate cortex and precuneus (Utevsky et al., 2014; Hagmann et al.,
2008). They are shown to be involved in the retrieval of autobiographic memories
and maintenance of the arousal state. The whole network is speculated to be
involved in the formation of self, social abilities, abilities to reflect about the past
and to plan (Andrews-Hanna, 2012).
Figure 8: fMRI scan of DMN regions; the medial prefrontal cortex, the posterior
cingulate cortex/precuneus, and the angular gyrus. Adapted from Wikipedia [7].
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Other important functional brain networks include, for example, the salience
network. Its main components are the anterior insula and dorsal anterior cingu-
late cortex. The network is called ”salience” as it is claimed to perceive what
stimuli are salient or meaningful to the brain, so then it can organize resources
around the detected important stimuli. It is involved in switching between DMN
and other networks, so it aims to regulate behavior states (Jilka et al., 2014).
There are many other different resting-state functional networks that are cur-
rently known. Some of them are shown in the Figure 9 and include language
network, sensoromotor network, and visual networks.
Figure 9: Functional resting-state networks of human brain. Adapted from
(Pievani et al., 2014)
Besides structural and functional connectivity, Karl Friston (Friston, 1994)
suggested the measure of effective connectivity. As he points out, the functional
connectivity is a simple measure of correlation between two or more activities of
units. And the correlation says nothing about the actual relationships between
them. Effective connectivity aims to provide missing information about how one
subunit affects another.
To sum up, a lot of data for human connectome were obtained. Now all of
them require to be better integrated together, so the analysis of it would reveal
further insights on human nervous system functioning, and in particular, on hu-
man cognition. Some simple analysis already revealed that human brain exhibits
small-worldness properties (Hagmann et al., 2008) with exponential degree dis-
tribution. It is also shown to have hubs and rich clubs, and, as authors speculate,
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the disturbances to these central hubs could potentially lead to neuropathologies




Neurodegenerative disorders have been studied for many decades. And for all
this time, the most known symptom of neurodegeneration was ongoing dementia,
which is a sharp cognitive decline over years. The earliest descriptions of age-
related dementia are known from all ancient cultures. And at the end of the 19th
century, it became an interest for doctors and neurologists who focused on the
postmortem examination of the brain tissues from patients with such dementia.
One of the most known cases is the case of Auguste D. which was described
in the paper in 1907 by a German professor Alois Alzheimer and the disease was
subsequently named after him (Strassnig and Ganguli, 2005). He worked with
her during all 4 years of disease progression and examined her brain after her
death and found prominent fibrillar tangled structures inside of otherwise normal
cells. He also described general changes of the brain, such as cortex thinning due
to loss of cells. Up until now, it is known as the main sign of Alzheimer’s disease
(AD) neurodegeneration.
Besides AD, there are several different pathologies considered neurodegener-
ative disorders. They are all quite distinct from each other and each occupies its
own brain area; thus, for example, frontotemporal dementia, or FTD is very sim-
ilar to Alzheimer’s in molecular signs but occurs in the frontal brain area while
AD is prevailing in a temporoparietal lobe. Figure 10 shows the localization of
different neurodegenerative pathologies in a brain. Modern medicine shows also
that they differ in their symptoms as well. While FTD, for example, affects widely
speaking ability and behavior, AD - cognitive abilities, and Parkinson’s disease
(PD) and Huntington’s disease - motor functions.
Figure 10: Localization of the main source of pathology for different neurodegen-
erative disorders. Adapted from (Bertram and Tanzi, 2005)
During the century after this first description of AD pathology, a lot more
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was learned about this and other neurodegenerative disorders. Although they
are different in many ways, some facts remain the same and allow us to study the
core principles of neurodegeneration. Many important breakthroughs were made
due to technological progress, which enabled researchers to conduct experiments
before considered impossible. First of such, signs of progress were made in histo-
logical and staining techniques, like the development of immunohistochemistry,
for example, allowed to better characterize the aggregation of misfolded proteins.
The development of visualization techniques, such as MRI and CT, gave sci-
entists the ability to look into the living brain, the invention of better microscopes
led us to see these pathologies in dead tissues much closer, and progress in genetics
opened a new way to look at the causes of these pathologies (Young, 2009).
The main processes leading to neurodegeneration are malfunctioning of genes,
protein misfolding, and network disruption; and they are to be described in the
following subchapters.
2.1.1 About misfolded proteins and their aggregation
Since the Alzheimer’s observation, it is clear that neurodegeneration and sub-
sequent symptoms correlate with pathogenic protein deposits. This observation
was confirmed by many other works as well, including the description of the
Prague group that was led by Oscar Fisher and Arnold Pick (Boller and Forbes,
1998). Similar deposits were observed also in pathologies that differ from AD,
like Parkinson’s disease and dementia with Lewy bodies, described by Frederic
Lewy (Engelhardt and Gomes, 2017).
In case of AD pathology, these deposits could be extracellular or intracellular.
Extracellular located deposits are called amyloid plaques. They are composed
of misfolded amyloid beta (Aβ) protein (Allsop et al., 1983; Glenner and Wong,
1984). This protein that originally functions as a part of transmembrane amy-
loid beta precursor protein to provide maintenance and growth for neurons but
after cleaved it forms fibrils that are components of amyloid plaques (Lu et al.,
2013). Both amyloid beta precursor protein and amyloid fibrils are illustrated
in the Figure 11. Once manifested plaques show local toxicity on the nearby
axons and attract microglia, brain immune cells, to the site, causing subsequent
inflammation (Meyer-Luehmann et al., 2008). These plaques also demonstrate a
great variability in terms of their structure (Tycko, 2015). This variability can be
the explanation of the clinical signs heterogeneity. Even though there is a high
correlation between plaques and AD it is important to note that some symptoms-
free patients also exhibit mild amounts of amyloid plaques (Iacono et al., 2008),
suggesting that it is not a key step in the neurodegeneration process.
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Figure 11: Illustration of amyloid beta precursor protein (on the left) and amyloid
beta fibril from a patient with Alzheimer’s disease (on the right). Images from
Protein Data Bank [4]
Intracellular deposits are neurofibrillary tangles, composed of tau protein
(Goedert et al., 1988). Tau proteins that usually serve to stabilize microtubules
essential for neuron functioning during the pathology progression are found to
be phosphorylated and lose their ability to bind microtubules (Bramblett et al.,
1993). Neurofibrillary tangles show higher correlation with cognitive decline in
patients (Bennett et al., 2004) which is consistent with the fact that amyloid
plaques appear as a first step of neurodegeneration, and with the mentioned fact
that plaques are observed in patients with no signs of ongoing dementia.
Not fully clear, however, stays the origin of initial protein misfolding and
aggregation. There is a piece of evidence, for example, for the genetic component
of amyloid plaque formation (discussed in the next chapter), this is, nevertheless,
not comprehensive. When this process is taking place too much, the brain does
not manage to mitigate and the neuron is affected by its surroundings. It seems
that when it does happen, the mentioned phosphorylation of tau occurs and
neurons become disrupted from inside as well, what potentially could trigger cell
death. Thus, initial fibril formation could be the first step towards a sequence of
events leading to cell loss and network disruption.
The similar was shown for other neurodegenerative disorders as well. Besides
amyloidopathies, synucleopathies occur. They are characterized by aggregation
of α-synuclein into fibrils and subsequent formation of Lewy bodies.
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2.1.2 Genetics of neurodegeneration
It was initially suspected that AD can be caused genetically because of quite
similar disorders noticed in people with Down syndrome (Masters et al., 1985).
By the time of first genetic research, it was already a fact that Down syndrome is
caused by a trisomy of the 21st chromosome, thus, the 21st chromosome was the
main suspect for carrying the mutation that causes AD. And soon it was localized
to be a gene of APP the cleaved product of which is the main constituent of
amyloid plaques (George-Hyslop et al., 1987; Goate, 1991). Together with this
gene PSEN1 and PSEN2 were identified (Sherrington et al., 1995). Presenilins
are proteins that form a γ-secretase complex. This secretase is responsible for
the cleavage of an APP and release of Aβ.
These studies, unfortunately, targeted only the familial form of Alzheimer’s
disease. This is a rare type of AD with a strong rate of inheritance and typi-
cally an earlier onset. For the sporadic form of AD, 21st chromosomes usually
carry a normal version of the APP gene, such a sporadic form is also referred as
Late-Onset Alzheimer’s disease (LOAD ). For this late-onset type a long time,
only one genetic risk factor was known: the APOE gene, the product of which
is an apolipoprotein E responsible for fat metabolism (Saunders et al., 1993).
Interestingly, some other genetic risk factors are found to be gene expressed not
in neurons but in other neural system cells such as microglia. Like for exam-
ple this genomic research showed the association of mutations in alleles of these
genes TREM2, ABI3, and PLCG2 (Consortium et al., 2017). All these genes
even though being expressed in all cell types of the cortex show much higher
expression levels in microglial cells. Gene products of them are building blocks
of very complex pathways which if generally speaking all serve the immune func-
tion of microglia. This suggests the importance which these cells and, in general,
immune functions play in the whole neurodegeneration process.
Other studies show also others possible risk-factor loci (Kamboh et al., 2012).
And it is clear that further studies will show many more of them. Taking to-
gether, it is obvious that genetic underprinting in the sporadic form of AD is not
homogenic. The genetic diversity of Alzheimer patients correlates well with al-
ready mentioned diversity of amyloid structure and clinical symptoms of disease
progression.
Although there are far more genetically deterministic neurodegenerative dis-
orders as well, such as Huntington’s disease (Hoogeveen et al., 1993), most of
the neurodegeneration diseases are the same heterogeneous in their genetics as is
Alzheimer’s. To conclude, although there are many correlations between genetics
and neurodegeneration, it can not be called a genetic disorder since its symptoms
are the result of much more complex interactions between many genetic factors
and environment.
2.2 Unifying hypotheses of neurodegeneration
It is undisputed that there is a considerable correlation between amyloid or amy-
loid beta specifically, and Alzheimer’s disease with all its clinical symptoms. Ge-
netic research also points out the enormous importance of amyloid beta as the
main constituent of later amyloid plaques, as has been discussed earlier. Thus,
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for some authors, mutations that have an influence on Aβ length and solubility
are the first step of neurodegeneration. Based on this and other data, Hardy J.
and Higgins G., for example, in 1992 paper proposed the amyloid cascade hy-
pothesis (Hardy and Higgins, 1992). According to them, the APP is the factor
that initiates the neurodegeneration cascade. As some mutations influence the
proteolysis of APP, thus, cause neurons to secrete more of the pathogenic form
of Aβ as they influence their surroundings causing damage to proximal neurons.
In response to this damage, neurons alternate the calcium influx into the cell. As
calcium is known to be the main second messenger of the cell and participates
in many cellular regulation pathways, it could be reasonable that it influences
the phosphorylation of tau protein as well, so generating intracellular tangles.
When this happens, it leads also to cell death. In the same paper, however, the
authors notice that their evidence is built on genetic studies of a familial form
of AD . Genetic research of the sporadic form, as was mentioned, leads to the
conclusion of other mechanisms possibly involved. 30 years later from this paper
publication, even more possible mechanisms are opened, if based on the genetic
research of SAD.
Other authors mention that Aβ secretion may not be exactly an initiation
factor but rather can be a normal physiological occurrence, based on evidence
that amyloid deposits do not always correlate with cognitive decline (Edwards,
2019; Iacono et al., 2008).
There are also a series of different works focusing on other players of neu-
rodegeneration. Microglial involvement could also shed light on what is going
on.
The subject of debate is also the way how neurodegeneration is progressing,
or how it propagates from its point of origin to almost all regions inside its brain
area. Since almost the first research in this area, there is a question of similarity
between neurodegeneration and prion-type diseases.
All the risen question are applicable not only for described forms of AD, but
for any other neurodegenerative disorder. As, in general, most of them starts
with genetics which is shown to not have any clear and easy causality but rather
a complex network of interaction. All of them, show some kind of proteinous
aggregations, rather from Aβ, synuclein or tau. And lastly, all seem to potentially
spread though prion-like mechanism and disrupt neural networks.
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3. Application of connectomics in
studies of neurodegeneration
3.1 Biomarkers of neurodegeneration
As was mentioned in a previous chapter, neurodegeneration is culminated in thin-
ning of a cerebral cortex due to cell loss; cell loss can not occur without connec-
tivity reduction as soon as dying neurons’ synapses also degenerate. Certain neu-
rons are playing the linking or central processing role in networks and their death
brings a potential risk of whole network disruption. Thus, it is said that con-
nectivity disruptions are linked to upstream and downstream neurodegenerative
processes. (processes laying upstream are molecular mechanisms that underlay
neurodegeneration when observed clinical symptoms are said to lay downstream.)
Connectivity disruptions are observed among many studied networks, both func-
tional and structural, and they are seen in almost all known neurodegeneration
diseases.
In Alzheimer’s disease spectrum, the most prominent changes occur among
functional networks: mainly, the activity of DMN is reduced in affected individ-
uals (Jones et al., 2017). The network also shows significant overlap with areas
primarily affected by tau and amyloid pathology or, in other words, with areas
rich in tau and amyloid deposits (Buckner et al., 2005). This suggests a link to
upstream events, though, the link is of uncertain causality; the most attractive
hypothesis suggests that protein pathology affects networks, however, it could
be explained and another way around, so that network activity could lead to
proteinopathy. The localization of tau deposits and subsequent changes in the
connectivity of the medial temporal lobe could explain the disease symptoms
since this area is active in memory retrieval; this area also corresponds to the
core of DMN that is also highly connected to other networks; the disruption of
it leads to the loss of the small worldness property of the brain, in other words,
the brain is less integrated and the mean length of pathways increases (Stam
et al., 2007). Changes of hippocampus - cortex connectivity, including hippocam-
pus connections to composite regions of DMN, correspond to memory formation
complications observed in Alzheimer’s patients (Wang et al., 2006). Moreover,
some of the studies above report an increase in changes in network connectivi-
ties as the disease progresses. Structural connectivity provides a physical basis
for the observed reduction in DMN functioning; it shows too the reduction of
white matter pathways in the limbic system and in cortical-cortical connections,
including the cingulum and the fornix -the major pathways coming through the
medial temporal lobe (Pievani et al., 2010).
Similarly, in frontotemporal dementia FTD, the most affected network re-
ported is the salience network, this is also confirmed by the reduction in underly-
ing structural tracts (Zhou et al., 2010). Likewise the findings of AD studies, this
data could be explained in accordance with the upstream and downstream events,
since there is also an overlap of affected networks with physical localization of
damage. Interestingly, the effect of FTD on networks is exactly the opposite of
the effect of Alzheimer’s, same as the observed clinical picture is also of opposite
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effects. In Parkinson’s disease, the most prominent changes are observed in the
structural pathways of the brainstem and in thalamocortical pathways, with the
progression of the disease seems to spread changes to structural connectivity of
other areas as well, and in more severe cases the damage is observed in many
areas including olfactory tracts, major interhemispheric, limbic, and extra motor
association tracts (Agosta et al., 2013). Depending on the degree of connectivity
disruption Parkinson’s patients also demonstrate cognitive decline (Hattori et al.,
2012).
It is worth mentioning that during normal healthy aging brain networks, both
structural and functional, also do not tend to stay the same. And the observed
change is similar to this in AD: the DMN shows lower activity; and similar to this
in other neurodegeneration diseases: lower salience and sensorimotor networks
(Damoiseaux, 2017). Generally, the older brain shows much higher integrity in
different networks, and lower integrity inside networks.
The described network changes themselves can not, unfortunately, reveal us a
clear picture of the disease onset and progression, since there are also studies that
show, for example, that people with FAD given by mutations in APOE4, exhibit
modified network’s activity far before any disease manifestation (Quevenco et al.,
2020). Or, similarly, some differences in young default brain activities accounted
for future risk of AD development (Buckner et al., 2005). This would suggest that
the observed connectivity abnormalities are not the results of ongoing, although
early, neurodegeneration but are risk factors and results from the specific genetic
composition.
Nonetheless, the described alternations can provide alternative biomarkers for
disease recognition at early stages. Since symptoms appear first only after even
decades of neurodegenerative processes, good biomarkers could be very valuable
tools of diagnosis. They could provide information not only about possible risks
but also localize them. With the additional help of further biomarkers, like CSF
markers (typically Aβ and tau), it can help to determine the stage and subtype
of the disease (Vemuri et al., 2009). An interesting example comes from the
study of connectivity change in patients with Parkinson’s disease. The study
compared drug-naive PD patients with those who were treated with levodopa,
a popular medication against PD symptoms, and used knowledge of the rate of
atrophy observed from connectivity changes. This provides the possibility to use
connectivity alternations to test various drug efficiency against different disorders
as an alternative to cognitive and behavioral tests which could be much slower
and not reliable markers (Seeley et al., 2009; Esposito et al., 2013).
3.2 Transneural spread hypothesis
It was discussed earlier in the chapter that amyloid load localization overlaps
with DMN activity, this is shown in many studies. It was also mentioned that
some carriers of Alzheimer-associated mutations exhibit changes in brain network
activity even when not affected by the disease. For example, APOE ϵ4 carriers
show increased functional connectivity of the medial temporal lobe with the region
of DMN - posterior cingulate (PCC), and other peri-limbic regions (Dennis et al.,
2010). Both regions serve for memory retrieval and are reported to be damaged
by tau and Aβ deposition in Alzheimer’s. These data suggest the existence of
23
a backward correlation between networks and proteinopathy. It proposes that
network activity can regulate and guide future proteinopathy if such is at risk,
and raises the question of how exactly can network activity in a healthy brain
state predict future neurodegeneration process and severity.
Prion diseases are diseases stimulated by the appearance of prions in the
CNS, such diseases are, for example, scrapie in sheep, mad cow disease, or
Creutzfeldt–Jakob disease (CJD) in humans. In a certain sense, prion diseases
are also the same as neurodegeneration proteinopathy, since it starts with pro-
tein misfolding. Prion diseases, however, are different from neurodegeneration
because they are considered infectious. Certain misfolded proteins can affect
other these proteins in a native conformation and turn them to conformational
change (Prusiner, 1982; Pan et al., 1993). These proteins spread involving more
proteins in a misfolding state and creating aggregates much similar to that of neu-
rodegeneration. As this happens, different brain areas get affected and collapse
their functionality at some point. This disease is considered fatal, and, similarly
to neurodegeneration in humans, mainly appears in older age.
Neurodegeneration in the brain always starts in a certain area and proceeds
in development in a predictable manner. The mechanism of neurodegeneration
spread still remains unclear, but increasing evidence is made of so-called transneu-
ronal spread. This hypothesis states that the misfolded protein aggregates in
neurodegenerative diseases spread along with existing neural networks by mech-
anisms similar to that of prions, so that each next affected protein is misfolded
with the aid of previous, and via cell-to-cell transmission, they travel through
neurons. This was partially proved by experimental science and showed amyloid
prion-like action on in vitro models (Baker et al., 1993), or transneuronal tau
transmission in vivo (Liu et al., 2012). Additional proof to this hypothesis comes
from connectomics. First of all, the motivation for this hypothesis comes from
already described and widely observed data of overlapping protein deposits and
existing neural networks and their activity. Secondly, a series of studies confirmed
this hypothesis with resting-state fMRI data. Central nodes with minimal path
length to all other nodes, and specifically closer to disease epicenters, in networks,
show greater vulnerability to disease, since their location makes them closer to
the disease onset place and, thus, they are first to be affected in the transneuronal
spread hypothesis. The same is true for other network nodes, that are usually
affected later in disease progression. Those that are closer to epicenters are more
at risk (Zhou et al., 2012). Importantly, models built on the basis of transneu-
ronal transmission are able to predict future layout of brain atrophy and damage
in real life patients (Raj et al., 2012).
There are also alternative hypotheses of neurodegeneration spread, such as
the hypothesis of nodal stress, trophic failure hypothesis, or shared vulnerabil-
ity hypothesis (Zhou et al., 2012). All of them make sense in the light of the
connectomics perspective and require further investigation using connectomics
methods. Therefore, connectomics provides not only ”supportive” research but




Neurodegenerative diseases were a long time conceptualized on the subsystem
level. The pathology was studied separately from the place where it occurs. The
diseases are used to be called proteinopathies since for a long time it was known
that they start with misfolding and aggregation of certain proteins. They were
used for medical diagnosis and actively studied. They could not, however, fully
explain the observed clinical signs, same as the subsystem approach, cannot fully
explain the whole phenomenon. Symptoms could vary person-to-person, although
the underlying protein pathology would be the same. The systems approach
and the network perspective are able to describe the observed symptoms and
to explain how the small events of protein misfolding translate into whole-brain
disease. And the connectomical data are aimed to help us to look at the brain
systematically. They are vital for our understanding of the disease: only they
can show how a certain phenotype is created, only they can help to trace the
spread of pathology. The fact that a higher education level decreases the risk of
neurodegeneration suggests (Roe et al., 2007) that network redundancy protects
the brain from this process; and motivates for looking for possible treatments
with network approaches too.
After all, the findings described in this chapter have several implications not
only for the study of neurodegeneration. They show us a new approach to all
brain diseases including such as schizophrenia and depression.
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Conclusion
In this thesis I have described what is connectomics. I went through its theo-
retical basis including its methods and main tools of analysis. I showed what
progresses neuroscientists achieved in this field with the example of C. elegans
and human connectome. I went through the main concepts of neurodegenera-
tion, even though a lot seems to be still unknown on this topic. Finally, I have
shown how using connectomics we can answer the fundamental questions about
neuropathology; I demonstrated the system-based proof of the transneural spread
hypothesis. Moreover, I discussed the possible usage of connectomics in clinical
practice.
All of this should show the potential of a connectomical approach, since it can
be applied for all known neuropathologies. It can be also used in fundamental
studies of cognition as it can reveal how the brain operates. An interesting topic
for future research would be the question of brain network evolution. I would
speculate that a lot of evolutionary constraints are invisible at the molecular and
anatomical levels and are given purely by network topology rules, so that it would
make it nearly impossible to understand brain evolution without diving deep into
connectomics.
On the contrary, it is clear, and many researchers point it out, that connec-
tomics has extremely ambitious goals. And they cannot be achieved fully in the
current technological state. Moreover, it is, for the moment, disintegrated; many
research groups work on different levels of it, with different methods. Public
integrated database exists but still appears to be more a collection of separate
research results.
But the Human Genome Project should teach us that if scientific community
cooperates, we, as humanity, are able to achieve the most ambitious goals and
connectomics should not be exception.
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